208 related articles for article (PubMed ID: 9753218)
1. Tirilazad widens the therapeutic window for riluzole-induced attenuation of progressive cortical degeneration in an infant rat model of the shaken baby syndrome.
Smith SL; Hall ED
J Neurotrauma; 1998 Sep; 15(9):707-19. PubMed ID: 9753218
[TBL] [Abstract][Full Text] [Related]
2. Infant rat model of the shaken baby syndrome: preliminary characterization and evidence for the role of free radicals in cortical hemorrhaging and progressive neuronal degeneration.
Smith SL; Andrus PK; Gleason DD; Hall ED
J Neurotrauma; 1998 Sep; 15(9):693-705. PubMed ID: 9753217
[TBL] [Abstract][Full Text] [Related]
3. Effects of the 21-amino steroid tirilazad mesylate (U-74006F) on brain damage and edema after perinatal hypoxia-ischemia in the rat.
Bågenholm R; Andiné P; Hagberg H
Pediatr Res; 1996 Sep; 40(3):399-403. PubMed ID: 8865275
[TBL] [Abstract][Full Text] [Related]
4. Direct measurement of hydroxyl radicals, lipid peroxidation, and blood-brain barrier disruption following unilateral cortical impact head injury in the rat.
Smith SL; Andrus PK; Zhang JR; Hall ED
J Neurotrauma; 1994 Aug; 11(4):393-404. PubMed ID: 7837280
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of the 21-aminosteroid lazaroid tirilazad mesylate (PNU-74006F) and the pyrrolopyrimidine lazaroid PNU-101033E on energy metabolism of human peripheral blood mononuclear cells.
Schmid D; Burmester GR; Tripmacher R; Fici G; von Voigtlander P; Buttgereit F
Biosci Rep; 2001 Feb; 21(1):101-10. PubMed ID: 11508689
[TBL] [Abstract][Full Text] [Related]
6. Neuronal degeneration and iNOS expression in experimental brain contusion following treatment with colchicine, dexamethasone, tirilazad mesylate and nimodipine.
Gahm C; Holmin S; Rudehill S; Mathiesen T
Acta Neurochir (Wien); 2005 Oct; 147(10):1071-84; discussion 1084. PubMed ID: 16044358
[TBL] [Abstract][Full Text] [Related]
7. Two novel pyrrolopyrimidine lipid peroxidation inhibitors U-101033E and U-104067F protect facial motor neurons following neonatal axotomy.
Smith SL; Oostveen JA; Hall ED
Exp Neurol; 1996 Oct; 141(2):304-9. PubMed ID: 8812165
[TBL] [Abstract][Full Text] [Related]
8. Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.
Hall ED; Andrus PK; Smith SL; Fleck TJ; Scherch HM; Lutzke BS; Sawada GA; Althaus JS; Vonvoigtlander PF; Padbury GE; Larson PG; Palmer JR; Bundy GL
J Pharmacol Exp Ther; 1997 May; 281(2):895-904. PubMed ID: 9152399
[TBL] [Abstract][Full Text] [Related]
9. Changes in local microvascular permeability and in the effect of intervention with 21-aminosteroid (Tirilazad) in a new experimental model of focal cortical injury in the rat.
Mathew P; Bullock R; Teasdale G; McCulloch J
J Neurotrauma; 1996 Aug; 13(8):465-72. PubMed ID: 8880610
[TBL] [Abstract][Full Text] [Related]
10. Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat.
McIntosh TK; Smith DH; Voddi M; Perri BR; Stutzmann JM
J Neurotrauma; 1996 Dec; 13(12):767-80. PubMed ID: 9002062
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia.
Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ
Neurosurgery; 1999 Jan; 44(1):163-71; discussion 171-2. PubMed ID: 9894977
[TBL] [Abstract][Full Text] [Related]
12. Time course of cerebral edema after traumatic brain injury in rats: effects of riluzole and mannitol.
Bareyre F; Wahl F; McIntosh TK; Stutzmann JM
J Neurotrauma; 1997 Nov; 14(11):839-49. PubMed ID: 9421455
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model.
Oostveen JA; Dunn E; Carter DB; Hall ED
J Cereb Blood Flow Metab; 1998 May; 18(5):539-47. PubMed ID: 9591846
[TBL] [Abstract][Full Text] [Related]
14. Riluzole attenuates cortical lesion size, but not hippocampal neuronal loss, following traumatic brain injury in the rat.
Zhang C; Raghupathi R; Saatman KE; Smith DH; Stutzmann JM; Wahl F; McIntosh TK
J Neurosci Res; 1998 May; 52(3):342-9. PubMed ID: 9590442
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.
Hall ED; Andrus PK; Smith SL; Oostveen JA; Scherch HM; Lutzke BS; Raub TJ; Sawada GA; Palmer JR; Banitt LS; Tustin JS; Belonga KL; Ayer DE; Bundy GL
Acta Neurochir Suppl; 1996; 66():107-13. PubMed ID: 8780807
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord.
Hall ED; Yonkers PA; Taylor BM; Sun FF
J Neurotrauma; 1995 Jun; 12(3):245-56. PubMed ID: 7473799
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lipid peroxidation attenuates axotomy-induced apoptotic degeneration of facial motor neurons in neonatal rats.
Hall ED; Smith SL; Oostveen JA
J Neurosci Res; 1996 May; 44(3):293-9. PubMed ID: 8723768
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury.
Smith SL; Scherch HM; Hall ED
J Neurosurg; 1996 Feb; 84(2):229-33. PubMed ID: 8592225
[TBL] [Abstract][Full Text] [Related]
19. Decreased red blood cells deformability in acute pancreatitis in the rat. Effect of tirilazad mesylate.
Chmiel B; Pajak J; Grabowska-Bochenek R; Cierpka L
Folia Med Cracov; 2003; 44(1-2):109-15. PubMed ID: 15232892
[TBL] [Abstract][Full Text] [Related]
20. Riluzole reduces brain swelling and contusion volume in rats following controlled cortical impact injury.
Stover JF; Beyer TF; Unterberg AW
J Neurotrauma; 2000 Dec; 17(12):1171-8. PubMed ID: 11186230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
